Literature DB >> 22493277

Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.

Lucas Xavier Bonfietti1, Marilena Dos Anjos Martins1, Maria Walderez Szeszs1, Sandra Brasil Stolf Pukiskas1, Sonia Ueda Purisco1, Fabiana Cortez Pimentel1, Graziella Hanna Pereira1, Dayane Cristina Silva1, Lidiane Oliveira1, Marcia de Souza Carvalho Melhem1.   

Abstract

The Candida parapsilosis group encompasses three species: C. parapsilosis, Candida orthopsilosis and Candida metapsilosis. These species are phenotypically indistinguishable, and molecular methods are needed for their detection. We analysed 152 unique blood culture isolates of the C. parapsilosis group obtained during 1997-2011. The isolates were screened by PCR amplification of the gene encoding secondary alcohol dehydrogenase, followed by digestion with the restriction enzyme BanI. Isolates with RFLP patterns distinct from those of the C. parapsilosis group were characterized as C. parapsilosis sensu stricto (90.8 %), C. orthopsilosis (8.6 %) and C. metapsilosis (0.6 %). Antifungal susceptibility tests indicated that all isolates were susceptible to itraconazole, amphotericin B and caspofungin. Although C. orthopsilosis and C. metapsilosis isolates were susceptible to fluconazole, higher MICs (≥2 mg l(-1)) were observed for C. orthopsilosis. Three isolates (2.0 %) of C. parapsilosis sensu stricto were resistant to voriconazole. Five C. parapsilosis isolates (3.3 %) were intermediate, and a single isolate (0.7 %) was resistant (MIC 16 mg l(-1)) to fluconazole. These data were confirmed using reference strains. It was observed that C. parapsilosis isolates were less susceptible to all triazoles, and this finding deserves further attention to assess the appearance of cross-resistance phenomena. In conclusion, C. metapsilosis and C. orthopsilosis are involved in a small but significant number of invasive infections in Brazil.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493277     DOI: 10.1099/jmm.0.037812-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

1.  Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.

Authors:  Maria Helena G Figueiredo-Carvalho; Leonardo S Barbedo; Manoel M E Oliveira; Fábio Brito-Santos; Rodrigo Almeida-Paes; Rosely M Zancopé-Oliveira
Journal:  Mycopathologia       Date:  2014-06-22       Impact factor: 2.574

2.  Capability of Fluorescent Capillary Electrophoresis To Distinguish Species of the Candida parapsilosis Complex.

Authors:  Iva Kotásková; Hana Obručova; Veronika Lýčková; Filip Růžička; Tomáš Freiberger
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.

Authors:  Marie Desnos-Ollivier; Stéphane Bretagne; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2022-04-12       Impact factor: 5.938

4.  Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.

Authors:  Luciana da Silva Ruiz; Sonia Khouri; Rosane Christine Hahn; Eriques Gonçalves da Silva; Vanessa Krummer Perinazzo de Oliveira; Rinaldo Ferreira Gandra; Claudete Rodrigues Paula
Journal:  Mycopathologia       Date:  2013-02-13       Impact factor: 2.574

5.  Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.

Authors:  Grazia Lovero; Elisa Borghi; Stella Balbino; Daniela Cirasola; Osvalda De Giglio; Federica Perdoni; Giuseppina Caggiano; Giulia Morace; Maria Teresa Montagna
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

6.  Characterization of virulence properties in the C. parapsilosis sensu lato species.

Authors:  Tibor Németh; Adél Tóth; Judit Szenzenstein; Péter Horváth; Joshua D Nosanchuk; Zsuzsanna Grózer; Renáta Tóth; Csaba Papp; Zsuzsanna Hamari; Csaba Vágvölgyi; Attila Gácser
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

7.  Genome comparison of Candida orthopsilosis clinical strains reveals the existence of hybrids between two distinct subspecies.

Authors:  Leszek P Pryszcz; Tibor Németh; Attila Gácser; Toni Gabaldón
Journal:  Genome Biol Evol       Date:  2014-05       Impact factor: 3.416

8.  The identification and differentiation of the Candida parapsilosis complex species by polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer region of the rDNA.

Authors:  Leonardo Silva Barbedo; Maria Helena Galdino Figueiredo-Carvalho; Mauro de Medeiros Muniz; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

9.  Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Ferry Hagen; Jacques F Meis; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

10.  Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.

Authors:  Henrique Marconi Sampaio Pinhati; Luiz Augusto Casulari; Ana Carolina Remondi Souza; Ricardo Andreotti Siqueira; Camila Maria Gomes Damasceno; Arnaldo Lopes Colombo
Journal:  BMC Infect Dis       Date:  2016-08-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.